IP Verse

Innopharma Licensing competitive analysis

Latest PTAB cases involving Innopharma Licensing

Discover the latest PTAB cases involving Innopharma Licensing, highlighting their recent legal challenges and patent disputes.

Last updated on: Feb 3, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Innopharma Licensing

IPR2017-00900Feb 17, 2017INNOPHARMA LICENSINGASTRAZENECAInstitution Denied
IPR2017-00900Feb 17, 2017INNOPHARMA LICENSINGASTRAZENECA ABInstitution Denied
IPR2017-00904Feb 17, 2017INNOPHARMA LICENSINGASTRAZENECAInstitution Denied
IPR2017-00904Feb 17, 2017INNOPHARMA LICENSINGASTRAZENECA ABInstitution Denied
IPR2017-00905Feb 17, 2017INNOPHARMA LICENSINGASTRAZENECAInstitution Denied
IPR2017-00905Feb 17, 2017INNOPHARMA LICENSINGASTRAZENECA ABInstitution Denied
IPR2016-00089Nov 2, 2015INNOPHARMA LICENSINGSENJU PHARMACEUTICALFinal Written Decision
IPR2016-00090Nov 2, 2015INNOPHARMA LICENSINGSENJU PHARMACEUTICALFinal Written Decision
IPR2016-00091Nov 2, 2015INNOPHARMA LICENSINGSENJU PHARMACEUTICALFinal Written Decision
IPR2015-00902Mar 19, 2015INNOPHARMA LICENSINGSENJU PHARMACEUTICALFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Innopharma Licensing with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jan 29, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
INNOPHARMA LICENSING - - 7 -
ASTRAZENECA - 27 - 18
ASTRAZENECA AB - - - 18
SENJU PHARMACEUTICAL - - - 14